VR Logo

Lasa Supergenerics Ltd. download report


Healthcare | Drugs & Pharma

Lasa Supergenerics Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Lasa Supergenerics Ltd. Annual Report
2020 Lasa Supergenerics Ltd. Annual Report Lasa Supergenerics Ltd. chairman speech Lasa Supergenerics Ltd. director's report Lasa Supergenerics Ltd. management discussion Lasa Supergenerics Ltd. corporate governance Lasa Supergenerics Ltd. auditor's report Lasa Supergenerics Ltd. account notes
2019 Lasa Supergenerics Ltd. Annual Report Lasa Supergenerics Ltd. chairman speech Lasa Supergenerics Ltd. director's report Lasa Supergenerics Ltd. management discussion Lasa Supergenerics Ltd. corporate governance Lasa Supergenerics Ltd. auditor's report Lasa Supergenerics Ltd. account notes
2018 Lasa Supergenerics Ltd. Annual Report Lasa Supergenerics Ltd. chairman speech Lasa Supergenerics Ltd. director's report Lasa Supergenerics Ltd. management discussion Lasa Supergenerics Ltd. corporate governance Lasa Supergenerics Ltd. auditor's report Lasa Supergenerics Ltd. account notes
2017 Lasa Supergenerics Ltd. Annual Report Lasa Supergenerics Ltd. chairman speech Lasa Supergenerics Ltd. director's report Lasa Supergenerics Ltd. management discussion Lasa Supergenerics Ltd. corporate governance Lasa Supergenerics Ltd. auditor's report Lasa Supergenerics Ltd. account notes

About The Company

Business: .

Incorporated: 2016

Chairman: Omkar Herlekar

Managing Director: Omkar Herlekar

Listing: BSE: 540702, NSE: LASA

Country: India

Headquarters: Raigad Dist, Maharashtra

Website: www.lasalabs.com

Key Facts

Market cap: ₹115.10 Cr

Revenue (TTM): ₹137.13 Cr

Earnings (TTM): ₹-5.37 Cr

Cash: ₹17.19 Cr

Total Debt: ₹19.46 Cr

Promoters' ownership: 43.78%

Liquidity: High

52 Week range: ₹27.80 - 88.50

Face value: ₹10.00

Shares outstanding: 4,06,72,668

6 Years Aggregate:

  • CFO: ₹132.59 Cr
  • EBITDA: ₹175.01 Cr
  • Net Profit: ₹29.08 Cr

Stock Performance

Time Period Lasa Supergenerics S&P BSE Healthcare S&P BSE Small Cap
YTD-58.89-17.34-15.40
1 month-34.87-3.61-2.73
3 months-31.97-10.54-9.88
1 Year-65.86-14.59-0.76
3 Years27.0518.8920.51
5 Years--9.1310.45
10 Years--12.3514.46
As on 29-Jun-2022
Year Lasa Supergenerics S&P BSE Small Cap S&P BSE Healthcare
2021-18.7762.7720.87
2020354.8432.1161.45
2019-43.44-6.85-3.55
2018-84.13-23.41-5.89